Chengcheng Pang
Papers
2
Total Citations
9
H-Index
2
About
Chengcheng Pang is a rising researcher in urologic oncology, specializing in minimally invasive surgical techniques and evidence-based outcomes for renal and prostate cancers. His work focuses on optimizing treatment pathways, particularly through robotic-assisted and ablative technologies. Pang’s major contributions include a seminal meta-analysis identifying key predictors for converting robotic-assisted partial nephrectomy to radical nephrectomy in renal cancer patients—a study that has garnered 5 citations and provides critical guidance for surgical decision-making. He also led a comparative analysis of high-intensity focused ultrasound (HIFU) partial gland ablation versus robot-assisted radical prostatectomy for localized prostate cancer, offering an evidence-based framework for balancing oncologic control with quality of life. With a total of 9 citations across his most-cited works, Pang’s research is shaping contemporary urologic practice by clarifying the risks and benefits of emerging therapies. His systematic reviews and meta-analyses are particularly notable for their methodological rigor, making him a valuable voice in the ongoing evolution of precision surgery and organ-sparing approaches.
Research Focus
Key Achievements
Top Papers
- 1
- 2